Zydus Cadila gets approval from USFDA for breast cancer drug

Posted on:07 Oct 2018 09:00:01
Zydus Cadila gets approval from USFDA for breast cancer drug
07 October 2018 Current Affairs:

Zydus Cadila, the major drug firm, has received the final approval from the U.S. Food and Drug Administration (USFDA) to market Exemestane tablets. The drug will be used for the treatment of breast cancer. The drug is made in the strength of 25 mg. The company will manufacture the drug at its group’s formulations SEZ facility in Ahmedabad.


Zydus Cadila, the major drug firm, has received the final approval from the U.S. Food and Drug Administration (USFDA) to market Exemestane tablets. The drug will be used for the treatment of breast cancer. The drug is made in the strength of 25 mg. The company will manufacture the drug at its group’s formulations SEZ facility in Ahmedabad.


Monthly Current Affairs

Fresherslive telegram Group

Current Affairs Section

Daily Current Affairs Quiz

Subscribe to Current Affairs

Enter your email to get daily current affairs

Current Affairs Weekly PDF

Current Affairs Monthly PDF

Current Affairs Quiz

Current Affairs Monthly PDF Hindi

Currentt Affairs 2019 January

22 JANUARY
NEWS
21 JANUARY
NEWS
20 JANUARY
NEWS
19 JANUARY
NEWS

Currentt Affairs 2018 December

31 DECEMBER
NEWS
30 DECEMBER
NEWS
29 DECEMBER
NEWS
28 DECEMBER
NEWS

Currentt Affairs 2018 November

30 NOVEMBER
NEWS
29 NOVEMBER
NEWS
28 NOVEMBER
NEWS
27 NOVEMBER
NEWS